RecruitingNot ApplicableNCT07540780

Social Media Support Groups for Adolescent Vaping Cessation


Sponsor

University of California, San Francisco

Enrollment

60 participants

Start Date

Apr 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to pilot test feasibility and acceptability of the Quit the Hit Toolkit, a social media-based nicotine vaping cessation program for adolescents and young adults, adapted for use in community settings.


Eligibility

Min Age: 13 Years

Inclusion Criteria7

  • English literacy
  • Age between 13-21 years (group participants) or 18+ (coaches, peer mentors)
  • Indicate they use social media "most" (>= 4) days per week (group participants)
  • Have vaped at least once per week in the past 30 days (90 percent of participants) (group participants)
  • Access to a computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
  • Indicate they are considering quitting or are interested in quitting with the next 6 months or within the next 30 days (group participants)
  • Currently reside in California, Minnesota, Oklahoma, or South Carolina

Exclusion Criteria7

  • No English literacy
  • Age under 13 or over 21 (group participants) or under 18 (coaches, peer mentors)
  • Insufficient social media use (3 or fewer days per week) (group participants)
  • Have not vaped at least once per week in past 30 days (group participants)
  • No access to computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
  • Not considering or interested in quitting vaping in the next 30 days or 6 months (group participants)
  • Not a resident of California, Minnesota, Oklahoma, or South Carolina

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSocial Media Intervention

Social media based intervention using Instagram with up to 3 posts per day for 30 days


Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07540780


Related Trials